Ex-Officio Members of the Advisory Committee on Breast Cancer in Young Women

Agency for Healthcare Quality and Research: Camille Fabiyi, Ph.D., M.P.H.

Dr. Fabiyi is the Senior Advisor for Women’s Health and Gender Research within the Office of Extramural Research, Education, and Priority Populations (OEREP) at the Agency for Healthcare Research and Quality (AHRQ).  In this role, she conducts, supports, and oversees research on women’s health, perinatal health and health disparities in the context of healthcare system quality and improvement and patient safety. She also provides leadership and represents AHRQ on all matters related to women’s health and gender research issues.  Prior to joining AHRQ, she served as a Senior Researcher in the Department of Obstetrics and Gynecology at the University of Chicago, where she conducted reproductive health research. Formerly, she served as the Project Director on federally funded research projects in the areas of maternal and child health and aging at the University of Illinois at Chicago (UIC). Dr. Fabiyi received her PhD in Community Health Sciences with a concentration in Maternal and Child Health and her MPH in Health Policy and Administration at the UIC School of Public Health.

Department of Defense: Gayle Vaday, Ph.D.

Dr. Vaday joined the Congressionally Directed Medical Research Programs (CDMRP) as a Grants Manager in January 2006 and became the Program Manager of the Breast Cancer Research Program (BCRP) in December 2006. Dr. Vaday coordinates all aspects of the acquisition program cycle, leading to the investment of congressional appropriations for the BCRP. She also oversees the Breast Cancer Research Semi-Postal funds allocated to the BCRP. She represents the Department of Defense as a member of the Interagency Breast Cancer Environmental Research Coordinating Committee. Dr. Vaday received her Ph.D. in Microbiology and Immunology from the University of Rochester. After completing postdoctoral training as a Feinberg Fellow at the Weizmann Institute of Science in Israel, Dr. Vaday served as a Research Scientist for the Northport Veterans Affairs Medical Center and Research Assistant Professor at Stony Brook University, where she conducted prostate and breast cancer research.

Department of Health and Human Services Office on Women’s Health: Vacant

Health Resources and Services Administration: Christina Lachance, M.P.H.

Christina Lachance is the Senior Advisor for the HRSA Office of Women’s Health within the U.S. Department of Health and Human Services. She provides expertise in coordinating women’s health-related activities across the agency and strengthening the programmatic focus to reduce sex and gender-based disparities to support comprehensive, culturally competent, and high quality health care. Prior to joining HRSA, Ms. Lachance led an ambitious effort to transform the Title X Family Planning Annual Report into an interoperable data system that leveraged health information technology standards for the HHS Office of Population Affairs. In previous federal positions, Ms. Lachance oversaw grantee evaluation activities for the former HHS Office of Adolescent Pregnancy Programs and conducted social behavioral research within NIH’s National Human Genome Research Institute examining how people learn and communicate about genetic risk and family health history. She began her public health career in a safety net hospital working with adolescents at-risk for or infected with HIV. She earned a bachelor’s degree from Tufts University and holds an MPH in Social and Behavioral Sciences from the Boston University School of Public Health.

Indian Health Service: RADM Michael Toedt, M.D., F.A.A.F.P.

Rear Adm. Michael Toedt serves as the Chief Medical Officer of the Indian Health Service. The IHS, an agency within the Department of Health and Human Services, is the principal federal health care provider for 2.3 million American Indians and Alaska Natives who are members of 573 federally recognized Tribes. As the CMO, Dr. Toedt is IHS’s lead expert on medical and public health topics, provides national leadership for the clinical and community-based health programs of the agency, and serves as the primary liaison and advocate for IHS health professionals. Dr. Toedt previously served as CMO for the Nashville Area, and as Acting Chief Medical Information Officer for the IHS. He earned his Bachelor of Science in applied physics with honor from the Georgia Institute of Technology and his Doctor of Medicine from the Uniformed Services University of the Health Sciences. He completed residency in family medicine and fellowship in obstetrics at the Franklin Square Hospital Center in Baltimore. He has served on numerous IHS and interagency committees, published several peer-reviewed articles, and holds several medical school clinical teaching appointments. He is board certified in family medicine and maintains active clinical privileges at several IHS and tribal facilities.

National Institutes of Health: Jung-Min Lee, M.D.

Dr. Lee is the Assistant Clinical Investigator in the Women Malignancies Branch of the National Cancer Institute. Dr. Lee is a graduate of Yonsei University, Wonju College of Medicine in South Korea. She completed residency training in internal medicine at the Albert Einstein Medical College, followed by a clinical research fellowship on breast cancer functional imaging at the Memorial Sloan-Kettering Cancer Center in New York. Dr. Lee came to the NCI for medical oncology training in the Medical Oncology Branch (MOB). Subsequently, she joined the Molecular Signaling Section/Women’s Cancers Clinic, MOB, to investigate potential biomarkers and develop rational combinations of targeted therapies for rare subsets of women’s cancers. Dr. Lee maintains her clinical focus in the development of early clinical trials for ovarian cancer and rare subsets of women’s cancers, such as BRCA1/2mut carriers with ovarian and/or breast cancers, or women with triple negative breast cancer (TNBC). Dr. Lee is a participating member in the Gynecologic Oncology Group, American Association for Cancer Research, American Society for Clinical Oncology, and the Breast and Gynecologic Malignancies Faculty of the CCR.

Page last reviewed: August 15, 2019